11 August 2022 · Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
9 November 2020 · There is very limited information on the use of corticosteroids during breastfeeding, although they are likely to be present in milk. Avoid prolonged high dose…
6 November 2020 · This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…
23 September 2020 · Topical corticosteroids are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid direct contact of the…
21 September 2020 · Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
21 September 2020 · The use of oropharyngeal anti-inflammatories/analgesics is not considered to present any risk to a breastfeeding infant. Doxycycline is considered to present negligible risk when used…
17 September 2020 · Preparations for treating otitis externa have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence…
29 May 2020 · Prednisolone 5mg orally is equivalent to hydrocortisone 20mg intravenously (equivalent anti-inflammatory dose). The peri-operative dose of hydrocortisone required may be higher than the equivalent prednisolone…